stop_circleTerminated/Withdrawn
Dermatitis, Atopic
Bayer Identifier:
16200
ClinicalTrials.gov Identifier:
EudraCT Number:
EU CT Number:
Not Available
Efficacy/safety study to explore a new topical formulation in Atopic Dermatitis
Trial purpose
The study shall explore whether treatment of atopic dermatitis is equally effective with Phoenix medical device as compared to standard therapy (Hydrocortisone cream).
Key Participants Requirements
Sex
BothAge
18 - 60 YearsTrial summary
Enrollment Goal
0Trial Dates
October 2013 - June 2014Phase
n/aCould I Receive a placebo
NoProducts
Phoenix (Dexpanthenol, BAY81-2996)Accepts Healthy Volunteer
NoWhere to participate
Status | Institution | Location |
---|---|---|
Terminated | proinnovera GmbH | Münster, 48155, Germany |
Secondary Outcome
- Number of participants with abnormal vital signsVital signs consist of blood pressure, heart rate and body temperature.date_rangeTime Frame:Up to 10 weeksenhanced_encryptionYesSafety Issue:
- Number of participants with adverse events as a measure of safety and tolerabilitydate_rangeTime Frame:Up to 10 weeksenhanced_encryptionYesSafety Issue:
Trial design
Trial Type
InterventionalIntervention Type
DeviceTrial Purpose
TreatmentAllocation
RandomizedBlinding
Single BlindAssignment
Parallel AssignmentTrial Arms
3